P1.16-29 Accelerated Hypofractionated Radiotherapy for Central Lung Tumors Unsuitable for Stereotactic Body Radiotherapy or Concurrent CRT

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.998
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Stereotactic Ablative Radiotherapy for Ultra-Central Lung Tumors: Prioritize Target Coverage or Organs at Risk?

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Spatially Fractionated Stereotactic Body Radiotherapy (Lattice SBRT) for Large Tumors

2020English

Stereotactic Body Radiotherapy for Pancreatic Cancer

Hong Kong Journal of Radiology
Nuclear MedicineRadiologyImaging
2017English

Stereotactic Body Radiotherapy for 186 Patients With Inoperable Lung Metastases

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Imaging Follow-Up After Stereotactic Ablative Radiotherapy (SABR) for Lung Tumors

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Stereotactic Body Radiotherapy for Early Stage Lung Cancer: A Multicentric Study

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Standardization of Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2015English

Optimal Patient Selection for Stereotactic Body Radiotherapy

The Lancet Oncology
Oncology
2019English

P1.16-22 Meta-Analysis of Stereotactic Ablative Radiotherapy Versus Surgery for Early Stage Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy